BRIEF-Zevra Announces Closing Of Sale Of Rare Pediatric Disease Priority Review Voucher

Reuters
07 Apr
BRIEF-Zevra Announces Closing Of Sale Of Rare Pediatric Disease Priority Review Voucher

April 7 (Reuters) - Zevra Therapeutics Inc ZVRA.O:

  • ZEVRA ANNOUNCES CLOSING OF SALE OF RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER FOR $150 MILLION

Source text: ID:nGNX97rQJ1

Further company coverage: ZVRA.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10